• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic launches MiniMed 630G in U.S.

Medtronic launches MiniMed 630G in U.S.

August 11, 2016 By Brad Perriello

Medtronic MiniMed 630GMedtronic (NYSE:MDT) announced  the U.S. launch of the MiniMed 630G insulin management system it developed to work with a blood glucose meter made by Ascensia Diabetes Care.

The MiniMed 630G uses Medtronic’s SmartGuard software and a continuous glucose monitor to warn patients when glucose levels reach a preset low and to cease insulin delivery if the user doesn’t respond to the alarm, the Fridley, Minn.-based company said. Medtronic debuted the SmartGuard tech when it won pre-market approval for the MiniMed 530G system (the company has also reportedly filed for pre-market approval from the FDA for its MiniMed 670G “artificial pancreas”).

The MiniMed 630G is also designed to link wirelessly to Ascensia’s ContourNext Link 2.4 finger-prick blood glucose meter, which can calculate and remotely deliver bolus doses and calibrate the CGM sensor. The duo re-upped their 5-year partnership in June. Ascensia was formed in January through the sale of Bayer‘s (ETR:BAYN) Diabetes Care biz toPanasonic (NYSE:PC).

“This latest innovation demonstrates Medtronic’s vision to transform diabetes care to enable greater freedom and better health through a commitment to continually improving both outcomes and user experience,” intensive insulin management president Alejandro Galindo said in prepared remarks.

“Low blood sugar at night is of particular concern, when up to 75% of severe hypoglycemia occurs and patients are unlikely to be aware of symptoms while they are asleep,” added Dr. Satish Garg of the University of Colorado’s Barbara Davis Center for Childhood Diabetes. “The ability to automate the suspension of insulin at night is an important feature as prolonged hypoglycemia could be life-threatening.”

In a separate release, Ascensia Diabetes Care U.S. president Robert Schumm said his company is “delighted” by the

“The accuracy of our blood glucose monitoring system combined with the new innovative technology of the MiniMed 630G system will truly help people with diabetes manage their condition,” Schumm said. “Meter accuracy is particularly important for insulin pump users with regard to CGM calibration and insulin bolus calculations. The launch of the CountourNext Link 2.4 meter as part of the MiniMed 630G system means people with diabetes in the U.S. now have access to highly accurate blood glucose monitoring, with the latest advancements in fully integrated insulin pumps.”

Filed Under: Diabetes Tagged With: Ascensia Diabetes Care, Medtronic, MiniMed

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy